NextGen Healthcare Named a Preferred EHR Vendor by Ohio Regional Extension Center

HORSHAM, Pa. (September 28, 2010) – NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), and leading provider of healthcare information systems and connectivity solutions, announced today that it has been named a preferred vendor of electronic health records by Ohio Health Information Partnership (OHIP), one of two federally designated regional extension centers (RECs) for Ohio.

NextGen® Ambulatory EHR version 5.6 will be part of a select group of products recommended by OHIP to physician practices, community health centers and critical access hospitals for use in meeting the Meaningful Use criteria and securing incentive payments under the American Recovery and Reinvestment Act.

“We are very pleased to be working with NextGen Healthcare to expand the reach of electronic health records in Ohio. This program will have a significant impact on the continuity of patient care, improving the lives of both patients and physicians,” said Fred Richards, COO and CIO of OHIP.

OHIP is a non-profit entity designated by the state and federal governments to advance the adoption, implementation, and Meaningful Use of health information technology among providers in Ohio. Awarded $28.5 million in federal stimulus funding, the organization’s goal is to transition 6,000 physicians to EHRs by February 2012.

“Partnering with OHIP is another important milestone for NextGen Healthcare and for providers striving toward meeting the Meaningful Use requirements,” said Scott Irwin, Director of Regional Extension Center Support at NextGen Healthcare. “Ohio-based physicians are set to benefit from our affordable software-as-a-service (SaaS) model, 24/7 training opportunities and money-back guarantee. As our national footprint of more than 100,000 users grows each day, we’re pleased to expand relationships with the regional extension centers as well.”

NextGen Healthcare was recently named a preferred or selected vendor by the regional extension centers in New York and Massachusetts, which have been charged with helping more than 12,000 physicians adopt EHRs. Both physicians and RECs can take advantage of the NextGen Path to Meaningful Use as a guide to using NextGen Ambulatory EHR to help meet Meaningful Use measures. NextGen Healthcare’s Grants Resource Center also helps clients apply for grant opportunities made possible by health reform, and its team of experienced, qualified physicians consults on implementation and optimal use of EHRs. Exclusive NextGen® solution certification is available to help HIT consultants and RECs best advise providers on using NextGen® products and services to become meaningful users.

More details about NextGen Healthcare’s support for the mission of regional extension centers can be found at http://www.nextgen.com/Stimulus/rec/rec.aspx along with an open letter to RECs from NextGen Healthcare president Scott Decker. For information about the Ohio Health Information Partnership, visit http://www.ohiponline.org.

About NextGen Healthcare

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen or Facebook at http://www.facebook.com/NextGenHealthcare.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: the volume and timing of systems sales and installations; length of sales cycles and the installation process; the possibility that products will not achieve or sustain market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company’s ability or inability to attract and retain qualified personnel; possible regulation of the Company’s software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods’ financial statements; general economic conditions; and the risk factors detailed from time to time in the Company’s periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company’s quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company’s revenues and operating results are very difficult to forecast. A major portion of the Company’s costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company’s period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact
NextGen Healthcare
Kristy DelMuto, 215-657-7010
kdelmuto@nextgen.com

Source: NextGen Healthcare